November 1, 2016 / 8:41 PM / 3 years ago

BRIEF-Corcept Therapeutics Q3 gaap earnings per share $0.02

Nov 1 (Reuters) - Corcept Therapeutics Inc

* Says expects that its revenue for 2016 will be $79-82 million, an increase from its original guidance of $76-81 million

* Corcept therapeutics announces third quarter 2016 financial results and provides corporate update

* Q3 gaap earnings per share $0.02

* Sees fy 2016 revenue $79 million to $82 million

* Q3 revenue $21.7 million versus i/b/e/s view $21.2 million

* Q3 earnings per share view $0.01 — Thomson Reuters I/B/E/S

* Q3 non-gaap earnings per share $0.04 excluding items Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below